Published: February 4, 2016 | DOI: 10.1371/journal.pone.0147860
Abstract
Objective
Smoking is associated with gastroesophageal reflux disease (GERD). Varenicline, a nicotinic receptor partial agonist, is used to aid smoking cessation. The purpose of this study was to prospectively
examine the long-term benefits of smoking cessation on GERD and health-related quality of life (HR-QOL).
...
Read More
Phone: +1 (925) 932-6330